PL377443A1 - Kompozycja do leczenia zmarszczek, drobnych zmarszczek i nadmiernego pocenia się oraz sposób jej zastosowania - Google Patents
Kompozycja do leczenia zmarszczek, drobnych zmarszczek i nadmiernego pocenia się oraz sposób jej zastosowaniaInfo
- Publication number
- PL377443A1 PL377443A1 PL377443A PL37744303A PL377443A1 PL 377443 A1 PL377443 A1 PL 377443A1 PL 377443 A PL377443 A PL 377443A PL 37744303 A PL37744303 A PL 37744303A PL 377443 A1 PL377443 A1 PL 377443A1
- Authority
- PL
- Poland
- Prior art keywords
- hyperhidrosis
- wrinkles
- compositions
- treatment
- fine lines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/334,887 US6866856B2 (en) | 2002-12-31 | 2002-12-31 | Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
PL377443A1 true PL377443A1 (pl) | 2006-02-06 |
Family
ID=32655203
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377443A PL377443A1 (pl) | 2002-12-31 | 2003-12-17 | Kompozycja do leczenia zmarszczek, drobnych zmarszczek i nadmiernego pocenia się oraz sposób jej zastosowania |
PL395231A PL395231A1 (pl) | 2002-12-31 | 2003-12-17 | Sposób zmniejszania nadmiernego pocenia się skóry |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL395231A PL395231A1 (pl) | 2002-12-31 | 2003-12-17 | Sposób zmniejszania nadmiernego pocenia się skóry |
Country Status (9)
Country | Link |
---|---|
US (1) | US6866856B2 (pl) |
EP (1) | EP1471874A4 (pl) |
JP (1) | JP2006514657A (pl) |
AU (1) | AU2003303628B2 (pl) |
BR (1) | BR0307124A (pl) |
CA (1) | CA2470201C (pl) |
MX (1) | MXPA04006896A (pl) |
PL (2) | PL377443A1 (pl) |
WO (1) | WO2004060326A1 (pl) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1301213B1 (en) * | 2000-07-21 | 2017-01-18 | ReVance Therapeutics, Inc. | Multi-component biological transport systems |
US20040220100A1 (en) * | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
US6916120B2 (en) * | 2002-01-30 | 2005-07-12 | Adc Telecommunications, Inc. | Fiber optic connector and method |
US20040131565A1 (en) * | 2002-10-29 | 2004-07-08 | Lee Letica | Lipstick composition containing essential oils |
US7476222B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of reducing the appearance of pigmentation with galvanic generated electricity |
US8734421B2 (en) * | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
US7480530B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Device for treatment of barrier membranes |
US7477940B2 (en) | 2003-06-30 | 2009-01-13 | J&J Consumer Companies, Inc. | Methods of administering an active agent to a human barrier membrane with galvanic generated electricity |
US7507228B2 (en) | 2003-06-30 | 2009-03-24 | Johnson & Johnson Consumer Companies, Inc. | Device containing a light emitting diode for treatment of barrier membranes |
US7477938B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Cosumer Companies, Inc. | Device for delivery of active agents to barrier membranes |
US7479133B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating acne and rosacea with galvanic generated electricity |
US7477941B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of exfoliating the skin with electricity |
US7486989B2 (en) | 2003-06-30 | 2009-02-03 | Johnson & Johnson Consumer Companies, Inc. | Device for delivery of oxidizing agents to barrier membranes |
US7477939B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating a wound with galvanic generated electricity |
US8404249B2 (en) | 2004-03-03 | 2013-03-26 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
US8092788B2 (en) * | 2004-03-03 | 2012-01-10 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
US20060135383A1 (en) * | 2004-12-17 | 2006-06-22 | Cossa Anthony J | Cleansing compositions comprising polymeric emulsifiers and methods of using same |
BRPI0519024A2 (pt) * | 2004-12-22 | 2008-12-23 | Avon Prod Inc | mÉtodo e composiÇço para reduzir a aparÊncia de rugas |
DE602006021547D1 (de) | 2005-03-03 | 2011-06-09 | Revance Therapeutics Inc | Zusammensetzungen und methoden zur topischen anwendung und zur transdermalen verabreichung eines oligopeptids |
US9180081B2 (en) * | 2005-03-03 | 2015-11-10 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
ES2259928B1 (es) | 2005-04-08 | 2007-11-01 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales. |
WO2007038252A2 (en) * | 2005-09-22 | 2007-04-05 | Key Douglas J | Methods and compositions for treating skin lines and wrinkles and improving skin quality |
US8518414B2 (en) * | 2005-11-17 | 2013-08-27 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
US7544375B1 (en) | 2006-06-12 | 2009-06-09 | Swiss Skin Repair, Inc. | Composition |
US8142818B2 (en) * | 2006-09-12 | 2012-03-27 | Himalaya Global Holdings Limited | Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof |
EP2109363A4 (en) * | 2006-12-29 | 2014-07-09 | Revance Therapeutics Inc | TRANSPORT MOLECULES USING HIV TAT POLYPEPTIDES WITH REVERSE SEQUENCE |
US20080233152A1 (en) * | 2006-12-29 | 2008-09-25 | Revance Therapeutics, Inc. | Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabilized with Polypeptide Fragments Derived from HIV-TAT |
JP2010524959A (ja) * | 2007-04-17 | 2010-07-22 | コドマン・アンド・シャートレフ・インコーポレイテッド | アルツハイマー病を処置するためのヘリウムガスボーラス中のクルクミンの鼻腔投与 |
US8383865B2 (en) * | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
WO2009045720A2 (en) * | 2007-09-28 | 2009-04-09 | Johnson & Johnson Consumer Companies, Inc. | Electricity-generating particulates and the use thereof |
US7745670B2 (en) * | 2008-06-27 | 2010-06-29 | Codman & Shurtleff, Inc. | Curcumin-Resveratrol hybrid molecule |
US7985776B2 (en) * | 2008-06-27 | 2011-07-26 | Codman & Shurtleff, Inc. | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease |
US20100082088A1 (en) * | 2008-08-27 | 2010-04-01 | Ali Fassih | Treatment of sweating and hyperhydrosis |
US8150525B2 (en) * | 2008-08-27 | 2012-04-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment of hyperhydrosis |
EP2330910B1 (en) * | 2008-09-11 | 2017-08-16 | Israeli Biotechnology Research Ltd. | Cosmetic use of leucojum bulb extracts |
US7723515B1 (en) | 2009-01-26 | 2010-05-25 | Codman & Shurtleff, Inc. | Methylene blue—curcumin analog for the treatment of alzheimer's disease |
US20100286585A1 (en) * | 2009-01-26 | 2010-11-11 | Codman & Shurtleff, Inc. | Shunt Delivery of Curcumin |
US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
KR101226660B1 (ko) | 2009-06-19 | 2013-01-25 | 일동제약주식회사 | 투센다닌 또는 멀구슬나무 추출물을 유효성분으로 함유하는 치매 예방 또는 치료용 조성물 |
JP5616045B2 (ja) * | 2009-10-05 | 2014-10-29 | 花王株式会社 | セラミド産生促進剤及び保湿剤 |
CN105147702B (zh) | 2009-10-05 | 2018-05-11 | 花王株式会社 | 神经酰胺产生促进剂以及保湿剂 |
JP5689247B2 (ja) * | 2010-04-28 | 2015-03-25 | 花王株式会社 | セラミド産生促進剤及び保湿剤 |
KR20120091335A (ko) * | 2009-11-13 | 2012-08-17 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 갈바닉 피부 치료 장치 |
JP2011105666A (ja) * | 2009-11-19 | 2011-06-02 | Kao Corp | ドーパオキシダーゼ活性抑制剤及び美白剤 |
US8747383B2 (en) | 2009-12-18 | 2014-06-10 | University Medical Pharmaceuticals Corp. | Process and system for iontophoretic wrinkle reduction |
KR20110091461A (ko) * | 2010-02-05 | 2011-08-11 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 갈바니 미립자를 포함하는 립 조성물 |
CN102781406B (zh) * | 2010-03-01 | 2015-07-08 | 强生消费者公司 | 具有理想的整体颜色的护肤组合物 |
US20110236491A1 (en) * | 2010-03-25 | 2011-09-29 | Jeannette Chantalat | Topical anti-inflammatory composition |
JP2012167023A (ja) * | 2011-02-09 | 2012-09-06 | Kao Corp | セラミド産生促進剤、保湿剤及び皮膚外用剤 |
JP2012167022A (ja) * | 2011-02-09 | 2012-09-06 | Kao Corp | セラミド産生促進剤、保湿剤及び皮膚外用剤 |
CN104039339B (zh) | 2011-11-07 | 2016-01-20 | 格瑞复斯(武汉)生化科技股份有限公司 | 肽类化合物作为神经递质分泌抑制剂 |
KR101723084B1 (ko) * | 2014-06-23 | 2017-04-04 | 대한민국 | 노밀린 또는 이의 약학적으로 허용 가능한 염을 포함하는 주름 개선 또는 피부 탄력 증진용 화장료 조성물 |
US20190015467A1 (en) * | 2017-07-12 | 2019-01-17 | Kao Corporation | Agent for preventing or ameliorating uneven skin tone |
US20220296489A1 (en) | 2018-06-13 | 2022-09-22 | Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.P.A. | Peptides having inhibitory activity on neuronal exocytosis |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5228854B2 (pl) * | 1974-06-27 | 1977-07-29 | ||
CH624011A5 (pl) | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4379454A (en) | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4708861A (en) | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
US4820724A (en) | 1986-03-31 | 1989-04-11 | University Of Southern California | Dual phase solvent carrier system |
US5223262A (en) | 1989-02-23 | 1993-06-29 | University Of Utah | Transdermal delivery system utilizing one way membranes |
US4956171A (en) | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5376363A (en) | 1991-05-03 | 1994-12-27 | Bristol-Myers Squibb Company | Clear gelled antiperspirant stick composition |
US5370873A (en) | 1992-09-11 | 1994-12-06 | Udeinya; Iroka J. | Therapeutic compounds derived from the neem tree |
AU690069B2 (en) * | 1993-02-09 | 1998-04-23 | Tulsa Forte Pharmacy Enterprises, Inc. | A method for stimulating hair growth with cationic derivatives of minoxidil using therapeutic iontophoresis |
USH1541H (en) | 1993-07-21 | 1996-06-04 | Holla; Kadambar S. | Method for producing azadirachtin concentrates from neem seed materials |
JP3541049B2 (ja) * | 1993-11-12 | 2004-07-07 | 御木本製薬株式会社 | ヒアルロニダーゼ阻害剤 |
US6974578B1 (en) * | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
US5500209A (en) | 1994-03-17 | 1996-03-19 | The Mennen Company | Deodorant and antiperspirant compositions containing polyamide gelling agent |
FR2747308B1 (fr) * | 1996-04-11 | 1998-07-10 | Shrivastava Ravi | Association de margousier, de (-) hydroxycitrate et de ceramides et compositions les renfermant |
US5932229A (en) | 1996-04-25 | 1999-08-03 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5834513A (en) | 1996-04-25 | 1998-11-10 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5847003A (en) | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
US5998423A (en) | 1996-10-08 | 1999-12-07 | Therasys, Inc. | Methods for modulating melanin production |
US6338855B1 (en) | 1996-10-25 | 2002-01-15 | The Procter & Gamble Company | Cleansing articles for skin and/or hair which also deposit skin care actives |
US5885600A (en) | 1997-04-01 | 1999-03-23 | Burlington Bio-Medical & Scientific Corp. | Natural insect repellent formula and method of making same |
AU735421B2 (en) | 1997-09-12 | 2001-07-05 | Procter & Gamble Company, The | Cleansing and conditioning article for skin or hair |
US6251400B1 (en) * | 1997-09-26 | 2001-06-26 | Kgk Synergize Inc | Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols |
US6239114B1 (en) * | 1997-09-26 | 2001-05-29 | Kgk Synergize | Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols |
WO2000024365A1 (en) | 1998-10-26 | 2000-05-04 | University Of Massachusetts | Treatment of skin with adenosine or adenosine analog |
DE19852981A1 (de) * | 1998-11-17 | 2000-05-18 | Martin Schmidt | Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen |
FR2787996B1 (fr) * | 1998-12-30 | 2002-05-10 | Dior Christian Parfums | Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique |
FR2793681B1 (fr) * | 1999-05-18 | 2001-06-22 | Oreal | Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides |
DE50016101D1 (de) * | 1999-08-13 | 2011-06-09 | Curadis Gmbh | Substanzen und mittel zur positiven beeinflussung von kollagen |
CN1306750A (zh) | 2000-01-28 | 2001-08-08 | 武长安 | 草本植物杀虫剂 |
US6753315B2 (en) | 2000-02-24 | 2004-06-22 | Brown University Research Foundation | α-bungarotoxin molecules and uses thereof |
IT1318425B1 (it) * | 2000-03-24 | 2003-08-25 | D B P Dev Biotechnological Pro | Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi. |
DE10021560A1 (de) * | 2000-05-03 | 2001-11-08 | Promelia Produkte Mit Naturext | Hautpflegemittel mit insektenrepellierender Wirkung |
JP2001316239A (ja) * | 2000-05-10 | 2001-11-13 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
JP3928153B2 (ja) * | 2001-01-19 | 2007-06-13 | コスメディ製薬株式会社 | シート状貼付剤 |
US20030091665A1 (en) * | 2001-11-09 | 2003-05-15 | Avon Products, Inc | Topical cosmetic composition with skin rejuvenation benefits |
US20030124205A1 (en) * | 2001-12-28 | 2003-07-03 | Avon Products, Inc. | Topical cosmetic composition having a natural plant active ingredient and method of using same |
-
2002
- 2002-12-31 US US10/334,887 patent/US6866856B2/en not_active Expired - Lifetime
-
2003
- 2003-12-17 JP JP2004565599A patent/JP2006514657A/ja active Pending
- 2003-12-17 BR BR0307124-3A patent/BR0307124A/pt not_active IP Right Cessation
- 2003-12-17 AU AU2003303628A patent/AU2003303628B2/en not_active Ceased
- 2003-12-17 CA CA002470201A patent/CA2470201C/en not_active Expired - Fee Related
- 2003-12-17 PL PL377443A patent/PL377443A1/pl not_active IP Right Cessation
- 2003-12-17 EP EP03808508A patent/EP1471874A4/en not_active Withdrawn
- 2003-12-17 MX MXPA04006896A patent/MXPA04006896A/es active IP Right Grant
- 2003-12-17 WO PCT/US2003/040660 patent/WO2004060326A1/en active Application Filing
- 2003-12-17 PL PL395231A patent/PL395231A1/pl not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004060326A1 (en) | 2004-07-22 |
CA2470201C (en) | 2006-09-26 |
BR0307124A (pt) | 2004-12-07 |
EP1471874A1 (en) | 2004-11-03 |
JP2006514657A (ja) | 2006-05-11 |
AU2003303628A1 (en) | 2004-07-29 |
CA2470201A1 (en) | 2004-06-30 |
MXPA04006896A (es) | 2004-12-06 |
US6866856B2 (en) | 2005-03-15 |
PL395231A1 (pl) | 2011-09-12 |
US20040127556A1 (en) | 2004-07-01 |
AU2003303628B2 (en) | 2006-03-09 |
EP1471874A4 (en) | 2007-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL377443A1 (pl) | Kompozycja do leczenia zmarszczek, drobnych zmarszczek i nadmiernego pocenia się oraz sposób jej zastosowania | |
EP1583821A4 (en) | METHODS AND COMPOSITIONS FOR TREATING UROLOGICAL DISORDERS USING GENES 44390, 54181, 211, 5687, 884, 1405, 636, 4421, 5410, 30905, 2045, 16405, 18560, 2047, 33751, 52872, 14063, 20739, 32544, 43239, 44373, 51164, 53010, 16852, 1587, 2207, 22245, 2387, 52908, 69112, 14990, 18547, 115, 579 | |
HK1158493A1 (en) | Hair treatment agent composition and method for production thereof | |
IL208191A0 (en) | Compositions and methods for treating rage-associated disorders | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
HUP0400231A3 (en) | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer | |
EP1476471A4 (en) | FUNCTIONAL FOODS FOR THE TREATMENT, PROTECTION AND RESTORATION OF CONNECTIVE TISSUES | |
HK1074005A1 (en) | Compositions and methods for treating or preventing pneumococcal infection | |
IL174479A (en) | The derivatives of myastrin, pharmaceutical preparations containing them and their uses | |
EP1468118A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
EP1572118A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CANCER WITH 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
IL153359A0 (en) | Peptides, compositions and methods for the treatment of burkholderia cepacia | |
EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
IL164887A0 (en) | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | |
PL368035A1 (pl) | Kompozycje i sposoby leczenia raka | |
EP1558238A4 (en) | BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA | |
ZA200309962B (en) | Cosmetic compositions and contrast charts for characterization thereof. | |
GB0205531D0 (en) | Hair treatment compositions | |
HUP0600855A3 (en) | Androgen pharmaceutical composition for treating depression | |
IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
AU2003275433A8 (en) | Compositions and methods for treating pain | |
AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
GB0106316D0 (en) | Apparatus for use in the treatment of hair | |
AU2003240174A8 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
AU2002332244A8 (en) | Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VDSO | Invalidation of derivated patent or utility model |
Ref document number: 395231 Country of ref document: PL Kind code of ref document: A1 |